A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Recruiting now · Phase 3
Conditions studied: Uterine Fibroids, Endometriosis
In brief
The purpose of this clinical trial to characterize changes in bone mineral density during continuous treatment with relugolix combination tablet for up to 48 months (4 years) and 1 year of post-treatment follow-up in premenopausal women with heavy menstrual bleeding associated with uterine leiomyomas (fibroids) or with moderate-to-severe pain associated with endometriosis.
Key facts
- Study ID
- NCT05862272
- Run by
- Sumitomo Pharma Switzerland GmbH
- People needed
- 1000
- Starts
- 2023-08-14
- Expected to finish
- 2030-09-01
- Last updated by the study team
- 2025-08-06
Who can join
Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Chandler — Chandler, Arizona, United States (enrolling)
- Mesa — Mesa, Arizona, United States (enrolling)
- Peoria — Peoria, Arizona, United States (enrolling)
- Phoenix — Phoenix, Arizona, United States (enrolling)
- Tucson — Tucson, Arizona, United States (enrolling)
- Burbank — Burbank, California, United States (enrolling)
- Canoga Park — Canoga Park, California, United States (enrolling)
- Encinitas — Encinitas, California, United States (enrolling)
- Inglewood — Inglewood, California, United States (enrolling)
- Lomita — Lomita, California, United States (enrolling)
- Long Beach — Long Beach, California, United States (enrolling)
- Los Angeles — Los Angeles, California, United States (enrolling)
- Sacramento — Sacramento, California, United States (enrolling)
- San Fernando — San Fernando, California, United States (enrolling)
- Stanford — Stanford, California, United States (enrolling)
- Valley Village — Valley Village, California, United States (enrolling)
- Aurora — Aurora, Colorado, United States (enrolling)
- Greenwood Village — Greenwood Village, Colorado, United States (enrolling)
- Lakewood — Lakewood, Colorado, United States (enrolling)
- Washington — Washington D.C., District of Columbia, United States (enrolling)
- Aventura — Aventura, Florida, United States (enrolling)
- Deland — DeLand, Florida, United States (enrolling)
- Hialeah — Hialeah, Florida, United States (enrolling)
- Kissimmee — Kissimmee, Florida, United States (enrolling)
- Mobile — Mobile, Alabama, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.